___

• Kaynaklar 1. Sperling MA, Tamborlane WV, Battelino T, et al. Diabe-tes Mellitus. In: Sperling M, ed. Pediatric Endocrinology,Fourth ed, 2014: 846-900. 2. Ize-Ludow D, Sperling M. The classification of DiabetesMellitus: A conceptual Framework. Pediatr Clin N Am2005; 52, 1533-52. 3. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 dia-betes. Lancet, 2013; S0140-6736: 60591-69597. 4. Eisenbarth GS. Update in type 1 diabetes. J Clin Endoc-rinol Metab 2007; 92: 2403-407. 5. Harjutsalo V, Sund R, Knip M, et al. Incidence of type1 diabetes in Finland. JAMA 2013; 310: 427-28. 6. Forlenza GP, Rewers M. The epidemic of type 1 diabetes:what is it telling us? Curr Opin Endocrinol Diabetes Obes2011; 18: 248-51. 7. Tuomilehto J. The emerging global epidemic of type 1 diabe-tes. Curr Diab Rep 2013 Doi: 10.1007/s11892-013-0433-5. 8. Libman IM, LaPorte RE, Becker DJ, et al. Was there anepidemic of diabetes in nonwhite adolescents in AlleghenyCounty, Pennsylvania? Diabetes Care 1998; 21:1278-81. 9. Akesen E, Turan S, Guran T, et al. Prevalence of type 1 dia-betes mellitus in 6–18-yr-old school children living in Istan-bul, Turkey. Pediatric Diabetes 2011; 12 (6): 567-71. 10. Demirbilek H, Ozbek MN, Baran RT. Incidence of type1 diabetes mellitus in Turkish children from the southeas-tern region of the country: A regional report J Clin ResPediatr Endocrinol 2013; 5 (2): 98-103. 11. Imagawa A, Hanafusa T, Miyagawa JI, et al. A novelsubtype of type 1 diabetes mellitus characterized by a ra-pid onset and an absence of diabetes- related autoantibo-dies. N Engl J Med 2000; 342: 301-307. 12. Knip M, Veijola R, Virtanen SM, et al. Environmentaltriggers and determinants of type 1 diabetes. Diabetes2005; 54, S125-S136. 13. Craig ME, Nair S, Stein H, Rawlinson WD. Viruses andtype 1 diabetes: a new look at an old story. Pediatr Dia-betes 2013; 14, 149-58. 14. Eisenbarth GS. Banting lecture 2009: an unfinished jo-urney: molecular pathogenesis to prevention of type 1 Adiabetes. Diabetes 2010; 59: 759-74. 15. Barrett JC, Clayton DG, Concannon P, et al. Genomewi-de association study and meta-analysis find that over 40 lociaffect risk of type 1 diabetes. Nat Genet 2009; 41: 703-707. 16. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 dia-betes. Lancet 2007, S0140-6736, 60591-60597. 17. Atkinson MA, Conrad B, Trucco M. Superantigens as etio-pathogenetic factors in the development of insulin depen-dent diabetes mellitus. Diabetes Metab Rev 1994; 10: 309. 18. Skyler JS. Primary and secondary prevention of type 1diabetes . Diabet Med 2013; 30: 161-69. 19. Barker JM, McFann KK, Orban T. Primary preventionof Type 1 A Diabetes? Are we there yet? Pediatr Diabe-tes 2007; 8: 115-16. 20. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type1 diabetes in first-degree relatives using a combination ofinsulin, GAD, and ICA512bdc/IA-s autoantibodies. Dia-betes 1996; 45: 926. 21. Schade DS, Eaton RP. The temporal relationship betwe-en endogeneously secreted stress hormones and metabo-lic decompensation in diabetic man. J Clin Endocrinol Me-tab 1980; 50: 131-36. 22. American Diabetes Association. Standards of medical carein diabetes –2011. Diabetes Care 2011; 34 Suppl 1: S11-61. 23. Foster DW, McGarry JD. The metabolic derangementsand treatment of diabetic ketoacidosis. New Engl J Med1983; 309: 159-69. 24. Wolfsdorf JI, Allgrove J, Craig ME, et al. Diabetic ke-toacidosis and hyperglycemic hyperosmolar state. PediatrDiabetes 2014; 15 (Suppl 20): 154-79. 25. Deeter KH, Roberts JS, Bradford H, et al. Hypertensi-on despite dehydration during severe pediatric diabetic ke-toacidosis. Pediatr Diabetes 2011: 12: 295-301. 26. Carlotti AP, St George-Hyslop C, Guerguerian AM, etal. Occult risk factor for the development of cerebral ede-ma in children with diabetic ketoacidosis: possible role forstomach emptying. Pediatr Diabetes 2009: 10: 522-33. 27. Sheikh-Ali M, Karon BS, Basu A, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacido-sis? Diabetes Care 2008: 31: 631-47. 28. Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis inchildren and the role of outpatient management. PediatrRev 1990: 11: 297-304. 29. Bagdure D, Rewers A, Campagna E, Sills MR. Epidemio-logy of hyperglycemic hyperosmolar syndrome in childrenhospitalized in USA. Pediatr Diabetes 2013: 14: 18–24. 30.Uçar A, Saka N, Baş F, et al. Frequency and severity of ke-toacidosis at onset of autoimmune type 1 diabetes over the pastdecade in children referred to a tertiary paediatric care cen-tre: potential impact of a national programme highlighted. JPediatr Endocrinol Metab 2013; 26 (11-12): 1059-65. 31. Hanas R, Lindgren F, Lindblad BA. 2-year national po-pulation study of pediatric ketoacidosis in Sweden: pre-disposing conditions and insulin pump use. Pediatr Dia-betes 2009: 10: 33–37. 32. Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ke-toacidosis occurring in newly diagnosed and establisheddiabetic children. Acta Paediatr 1998: 87: 537–41. 33. Morris AD, Boyle DI, McMahon AD, et al. Adherenceto insulin treatment, glycaemic control, and ketoacidosisin insulin-dependent diabetes mellitus. TheDARTS/MEMO Collaboration. Diabetes Audit and Re-search in Tayside Scotland. Medicines Monitoring Unit.Lancet 1997: 350: 1505–510. 34. Hanas R, Lindgren F, Lindblad BA. 2-year national po-pulation study of pediatric ketoacidosis in Sweden: pre-disposing conditions and insulin pump use. Pediatr Dia-betes 2009: 10: 33–37. 35. Cope JU, Morrison AE, Samuels-Reid J. Adolescent use ofinsulin and patient-controlled analgesia pump technology:a 10-year Food and Drug Administration retrospectivestudy of adverse events. Pediatrics 2008: 121: e1133–e1138. 36.Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPESconsensus statement on diabetic ketoacidosis in children andadolescents. Arch Dis Child 2004: 89: 188–94. 37. Monroe KW, King W, Atchison JA. Use of PRISM sco-res in triage of pediatric patients with diabetic ketoacido-sis. Am J Manag Care 1997: 3: 253–58. 38. Bonadio WA, Gutzeit MF, Losek JD, Smith DS. Outpa-tient management of diabetic ketoacidosis. Am J Dis Child1988: 142: 448–50. 39. Linares MY, Schunk JE, Lindsay R. Laboratory presen-tation in diabetic ketoacidosis and duration of therapy. Pe-diatr Emerg Care 1996: 12: 347–51. 40. Malik FS, Taplin CE. Insulin therapy in children and adoles-cents with type 1 diabetes. Pediatr Drugs 2014; 16: 141-50. 41. American Diabetes Association. Standards of medical carein diabetes---2014. Diabetes Care 2014; 37 (Suppl 1): 14-80. 42. Vurallı D, Kandemir N. Tip 1 Diabetes Mellitus. ÇocukEndokrinolojisi; Editörler: Cinaz, Darendeliler, Akıncı, veark., 2014; 15 (2): 399-452.